Study: Synthetic Cannabinoid Relieves PTSD-Associated Nightmares

OTTAWA — The administration of nabilone, a synthetic cannabinoid, mitigates the frequency and intensity of trauma-related nightmares in military personnel suffering from treatment-resistant post-traumatic stress, according to clinical trial data published in the journal Psychoneuroendocrinology.

Investigators from the Canadian Forces Health Services Group and the Operational Trauma and Stress Support Centre in Ottawa assessed the efficacy of nabilone, an FDA-approved selective CB1 agonist, versus placebo over a 16-week period in a cohort…